Regulus Therapeutics Inc (RGLS) Insider Trading
- $20,113,767.22
- $44,140,926.59
- July 25, 2024
- Isis Pharmaceuticals Inc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 23, 2014 | Director | 1,700 | $6.88 | Sell | $11,696.00 | |
| July 18, 2014 | Director | 5,000 | $6.80 | Sell | $34,000.00 | |
| July 17, 2014 | Director | 5,000 | $6.58 | Sell | $32,900.00 | |
| July 16, 2014 | Director | 3,500 | $6.59 | Sell | $23,065.00 | |
| July 11, 2014 | Director | 1,750 | $6.48 | Sell | $11,340.00 | |
| July 10, 2014 | Director | 4,500 | $6.69 | Sell | $30,105.00 | |
| July 9, 2014 | Director | 1,800 | $7.08 | Sell | $12,744.00 | |
| Feb. 4, 2014 | major shareholder | 1,303,780 | $7.67 | Buy | $9,999,992.60 | |
| Jan. 21, 2014 | Insider | 4,421 | $8.09 | Sell | $35,765.89 | |
| Jan. 17, 2014 | Insider | 4,479 | $8.15 | Sell | $36,503.85 | |
| Jan. 16, 2014 | Insider | 1,100 | $8.03 | Sell | $8,833.00 | |
| Jan. 2, 2014 | CEO | 3,505 | $7.25 | Sell | $25,411.25 | |
| Oct. 10, 2012 | Director | 750,000 | $4.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Regulus Therapeutics Inc stock.
The insider traders at Regulus Therapeutics Inc are: Isis Pharmaceuticals Inc, Joseph P Hagan, Alnylam Pharmaceuticals, Inc., Christopher Ray Aker, Kleanthis G Xanthopoulos, William H Rastetter, Daniel R Chevallard, Neil W Gibson, Neil Gibson, Stelios Papadopoulos, Kathryn J Collier, Bruce L A Carter, Pascale Witz, Paul Edward Walker, Peter J Barris, Sanofi, Stanley T Crooke, Denis Drygin, Crispina Calsada, and Kleanthis Xanthopoulos
The most active insider trader at Regulus Therapeutics Inc is Isis Pharmaceuticals Inc with 34 trades.
Isis Pharmaceuticals Inc has sold the most Regulus Therapeutics Inc stock with a total value of $28,417,089.94.
Sanofi has bought the most Regulus Therapeutics Inc stock with a total value of $19,999,985.20.
The most recent insider trade for Regulus Therapeutics Inc was on July 25, 2024.
The single biggest insider buy for Regulus Therapeutics Inc was from Sanofi with a total value of $9,999,992.60 on Feb. 4, 2014.
The single biggest insider sell for Regulus Therapeutics Inc was from Isis Pharmaceuticals Inc with a total value of $20,393,811.34 on Nov. 3, 2014.